The Drug Enforcement Administration (DEA) is preparing to expand its medical marijuana registration system to cover more of the state-licensed supply chain, with new applications expected soon for manufacturers, growers, distributors and testing labs.
The move follows DEA’s recent launch of a registration portal and form for medical marijuana dispensaries, giving retailers a pathway to register for federal protections tied to the Trump administration’s ongoing marijuana rescheduling process. That initial form, however, applied only to dispensaries, leaving cultivators, processors, labs and distributors without a clear option during the 60-day expedited registration window.
DEA now says the registration pathway will be extended to other businesses involved in bringing state-licensed medical marijuana products from cultivation to testing and distribution. The forms are expected to be posted through the agency’s Diversion Control Division, though DEA has not announced a specific release date.
The new registration system is tied to DOJ’s recent rescheduling order, which places state-regulated medical marijuana products and FDA-approved marijuana products in Schedule III rather than Schedule I. A June 29 hearing is set for the full rescheduling of cannabis.
Sponsored
